X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11775) 11775
Dissertation (54) 54
Book Chapter (30) 30
Publication (18) 18
Conference Proceeding (5) 5
Web Resource (3) 3
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxaliplatin (10474) 10474
humans (7144) 7144
oncology (6364) 6364
chemotherapy (5454) 5454
male (4541) 4541
female (4447) 4447
cancer (3916) 3916
middle aged (3905) 3905
aged (3766) 3766
colorectal cancer (3666) 3666
fluorouracil (3159) 3159
antineoplastic combined chemotherapy protocols - therapeutic use (2994) 2994
adult (2875) 2875
leucovorin (2479) 2479
colorectal neoplasms - drug therapy (2388) 2388
treatment outcome (2130) 2130
organoplatinum compounds - administration & dosage (2076) 2076
irinotecan (2039) 2039
colorectal neoplasms - pathology (1974) 1974
survival (1783) 1783
metastasis (1769) 1769
fluorouracil - administration & dosage (1757) 1757
cisplatin (1744) 1744
surgery (1681) 1681
5-fluorouracil (1627) 1627
capecitabine (1580) 1580
1st-line treatment (1543) 1543
bevacizumab (1499) 1499
aged, 80 and over (1429) 1429
antineoplastic combined chemotherapy protocols - adverse effects (1429) 1429
care and treatment (1398) 1398
pharmacology & pharmacy (1387) 1387
therapy (1311) 1311
prognosis (1241) 1241
disease-free survival (1211) 1211
trial (1196) 1196
neoplasm staging (1144) 1144
medicine & public health (1093) 1093
organoplatinum compounds - adverse effects (1088) 1088
combination (1081) 1081
antineoplastic agents - therapeutic use (1064) 1064
leucovorin - administration & dosage (1059) 1059
deoxycytidine - analogs & derivatives (1053) 1053
retrospective studies (1047) 1047
analysis (1035) 1035
antineoplastic combined chemotherapy protocols - administration & dosage (1025) 1025
animals (1019) 1019
camptothecin - analogs & derivatives (1006) 1006
research (1004) 1004
cancer therapies (995) 995
patients (991) 991
tumors (938) 938
liver neoplasms - secondary (932) 932
cetuximab (907) 907
gemcitabine (902) 902
survival rate (895) 895
organoplatinum compounds - therapeutic use (889) 889
colorectal-cancer (878) 878
carcinoma (845) 845
antineoplastic agents (826) 826
neoplasm metastasis (815) 815
metastases (789) 789
antineoplastic agents - adverse effects (782) 782
deoxycytidine - administration & dosage (775) 775
colorectal carcinoma (771) 771
phase-ii (770) 770
colon cancer (762) 762
clinical trials (753) 753
antimitotic agents (750) 750
liver neoplasms - drug therapy (749) 749
adenocarcinoma - drug therapy (746) 746
fluorouracil - therapeutic use (742) 742
drug therapy (738) 738
camptothecin - administration & dosage (735) 735
survival analysis (715) 715
apoptosis (706) 706
fluorouracil - adverse effects (696) 696
colorectal neoplasms - mortality (690) 690
toxicity (689) 689
cell line, tumor (683) 683
adenocarcinoma (682) 682
antineoplastic agents - pharmacology (682) 682
gastroenterology & hepatology (678) 678
chemotherapy, adjuvant (673) 673
antineoplastic agents - administration & dosage (657) 657
health aspects (656) 656
metastatic colorectal-cancer (626) 626
folinic acid (623) 623
adjuvant chemotherapy (615) 615
hematology, oncology and palliative medicine (613) 613
expression (607) 607
gastric cancer (606) 606
colon-cancer (604) 604
fluorouracil - analogs & derivatives (595) 595
randomized-trial (593) 593
drug administration schedule (592) 592
cancer research (582) 582
organoplatinum compounds - pharmacology (582) 582
phase-iii trial (579) 579
follow-up studies (554) 554
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11399) 11399
French (202) 202
German (161) 161
Japanese (127) 127
Chinese (61) 61
Spanish (33) 33
Korean (29) 29
Italian (19) 19
Russian (16) 16
Portuguese (11) 11
Polish (7) 7
Czech (5) 5
Dutch (3) 3
Norwegian (3) 3
Hungarian (2) 2
Turkish (2) 2
Arabic (1) 1
Icelandic (1) 1
Persian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Oncoimmunology, ISSN 2162-402X, 2015, Volume 4, Issue 4, p. e1008866
Journal Article
Journal Article
Annals of oncology, ISSN 0923-7534, 2018, Volume 29, Issue 5, pp. 1099 - 1107
Journal Article
Clinical neurophysiology, ISSN 1388-2457, 2018, Volume 129, Issue 3, pp. 694 - 706
•Symptoms after oxaliplatin infusion correlate with nerve excitability findings.•Oxaliplatin induces a slowing of sodium channel inactivation in motor nerve... 
Sodium channel dysfunction | Chemotherapy | Nerve excitability testing | Neuropathy | Quantitative sensory tests | Oxaliplatin toxicity | NERVE-FIBERS | COLORECTAL-CANCER SURVIVORS | VALIDATION | ANTICANCER DRUG | NEUROSCIENCES | CLINICAL NEUROLOGY | PAIN | PHARMACOKINETICS | PERIPHERAL NEUROPATHY | INDUCED NEUROTOXICITY | ASSOCIATION | Hyperalgesia - chemically induced | Neurotoxicity Syndromes - diagnosis | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Antineoplastic Agents - therapeutic use | Oxaliplatin - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Sodium Channels - metabolism | Adult | Female | Surveys and Questionnaires | Antineoplastic Agents - pharmacology | Neural Conduction - drug effects | Paresthesia - chemically induced | Motor Neurons - drug effects | Paresthesia - physiopathology | Paresthesia - metabolism | Hyperalgesia - metabolism | Axons - drug effects | Axons - metabolism | Hyperalgesia - physiopathology | Colorectal Neoplasms - physiopathology | Motor Neurons - metabolism | Oxaliplatin - pharmacology | Neurotoxicity Syndromes - physiopathology | Neurotoxicity Syndromes - metabolism | Aged | Antimitotic agents | Oncology, Experimental | Analysis | Colorectal cancer | Research | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 1899 - 15
Nanoparticles can potentially stimulate tumour microenvironments to elicit antitumour immunity. Herein, we demonstrate effective immunotherapy of colorectal... 
CALRETICULIN EXPOSURE | COLON-CANCER | ANTICANCER CHEMOTHERAPY | DENDRITIC CELLS | DRUG-DELIVERY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | IMMUNOGENIC CELL-DEATH | T-CELL | METRONOMIC CHEMOTHERAPY | ANTIGEN-PRESENTING FUNCTION | Neoplasm Transplantation | Polymers - administration & dosage | Reactive Oxygen Species - metabolism | Artemisinins - pharmacokinetics | Nanoparticles - chemistry | Cancer Vaccines - pharmacology | Colorectal Neoplasms - genetics | Humans | Immunologic Factors - chemical synthesis | Reactive Oxygen Species - agonists | Oxaliplatin - pharmacokinetics | Cancer Vaccines - chemical synthesis | Immunologic Factors - pharmacokinetics | Artemisinins - pharmacology | Colorectal Neoplasms - therapy | Reactive Oxygen Species - immunology | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cancer Vaccines - pharmacokinetics | Colorectal Neoplasms - mortality | Tumor Microenvironment - drug effects | Immunity, Innate - drug effects | Polymers - chemical synthesis | Drug Compounding - methods | Adenocarcinoma - immunology | Rats | Antibodies, Neutralizing - pharmacology | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Rats, Sprague-Dawley | Tumor Microenvironment - immunology | Oxaliplatin - pharmacology | Adaptive Immunity - drug effects | Animals | B7-H1 Antigen - antagonists & inhibitors | Colorectal Neoplasms - immunology | Adenocarcinoma - therapy | Survival Analysis | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Immunologic Factors - pharmacology | Adenocarcinoma - mortality | Reactive oxygen species | Adaptive systems | Drug delivery systems | Biodegradability | Colorectal carcinoma | Colorectal cancer | Antibodies | Drug delivery | Peripheral neuropathy | Immunity | Synergism | Immunosuppressive agents | Anticancer properties | Nanoparticles | Oxaliplatin | Immunotherapy | Polymers | Movement disorders | Immune system | Biodegradation | Coordination polymers | Immune response | Immunostimulation | Core-shell particles | Immune checkpoint | PD-L1 protein | Antitumor activity | Microenvironments | Physicochemical properties | Tumors | Cancer
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2019, Volume 393, Issue 10184, pp. 1948 - 1957
Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy... 
SURGERY | REGRESSION | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESECTION | CHEMORADIOTHERAPY | OPEN-LABEL | ESOPHAGEAL | CANCER | STOMACH | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Docetaxel - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Oxaliplatin - administration & dosage | Administration, Oral | Esophagogastric Junction - pathology | Treatment Outcome | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Digestive System Surgical Procedures | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Docetaxel - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma | Anthracyclines | Chemotherapy | Leucovorin | Product development | Esophageal cancer | Cancer | Intravenous administration | Control methods | Toxicity | Clinical trials | Oncology | Metastasis | Cancer therapies | Stomach cancer | Evidence-based medicine | Metastases | Confidence intervals | Infusion | Oxaliplatin | Surgery | Intravenous infusion | Epirubicin | Medical research | Survival | Patients | Cisplatin | Esophagus | Interactive systems | Medical prognosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article